07 Any serious or unexpected reaction Stop use and seek qualified medical care
Compare GHK-Cu Topical Serum by mechanism, evidence strength, expected timeline, side-effect profile, and whether its primary use case matches your goal
Published Phase 2 clinical trial data used doses of 1mg, 4mg, 8mg, and 12mg administered weekly via subcutaneous injection
You might brush it off as being a result of stress or disrupted sleep, but this is your bodys way of telling you that its running low on a vital nutrient
Lipotropic injections and pregnancy/breastfeeding (Precautions)
The standard KLOW dose is 3.2 mg total per injection: 2 mg GHK-Cu plus 0.4 mg each of BPC-157, TB-4, and KPV